KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Share-based Compensation (2020 - 2025)

Clover Health Investments' Share-based Compensation history spans 6 years, with the latest figure at $24.9 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 15.94% year-over-year to $24.9 million; the TTM value through Dec 2025 reached $103.7 million, down 9.34%, while the annual FY2025 figure was $103.7 million, 9.34% down from the prior year.
  • Share-based Compensation reached $24.9 million in Q4 2025 per CLOV's latest filing, down from $26.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $46.8 million in Q3 2021 to a low of $24.9 million in Q4 2025.
  • Average Share-based Compensation over 5 years is $34.3 million, with a median of $33.1 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: skyrocketed 3018.12% in 2021, then fell 25.43% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $31.2 million in 2021, then rose by 25.38% to $39.1 million in 2022, then fell by 15.24% to $33.1 million in 2023, then dropped by 10.54% to $29.6 million in 2024, then decreased by 15.94% to $24.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Share-based Compensation are $24.9 million (Q4 2025), $26.1 million (Q3 2025), and $26.2 million (Q2 2025).